In Re ZTE (USA) INC.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Reyna, Linn, and Hughes. On Petition for Writ of Mandamus to the Eastern District of Texas.
Summary: Under Federal Circuit law, the plaintiff bears the burden of showing that venue is proper. Further, an arms-length agreement with a call center in the relevant district is insufficient to show a regular and established place of business for venue.
ZTE USA was sued in the Eastern District of Texas for patent infringement and promptly moved to dismiss or transfer the case for lack of venue. Considering the motion, the magistrate judge applied Fifth Circuit law and determined that ZTE USA, as the objecting defendant, had the burden to show that venue was improper. The magistrate further found that ZTE USA had contracted with a call center in the Eastern District of Texas to handle ZTE USA related calls, which constituted a regular and established place of business. ZTE USA filed a petition for a writ of mandamus with the Federal Circuit asking the appellate court to reverse the decision.
At the Federal Circuit, the Court found that patent venue was a substantive issue of patent law and that the magistrate judge had incorrectly applied Fifth Circuit law instead of Federal Circuit law. The Court then determined that the plaintiff in a patent case has the burden of showing proper venue. Turning to the question of whether the call center was a regular and established place of business, the court held that an arms-length contract with the call center, without more, is insufficient to show a regular and established place of business. Instead the lower court should have considered the level of control ZTE USA exerted over the call center. The Federal Circuit then remanded the case back to the lower court to determine venue in light of the Federal Circuit’s decision.
This case is: In Re ZTE (USA) INC.
Written by: Daniel P. Hughes and Christie Matthaei
Edited by: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…